Novartis Pharma: The Business Unit Model
Saved in:
| Title: | Novartis Pharma: The Business Unit Model |
|---|---|
| Description: | In June 2000, Novartis reorganized its pharmaceutical business to form global business units in oncology, transplantation, ophthalmology, and mature products. The remaining primary care products continued to be managed within global functions (e.g., R&D and marketing). The new organization created a matrix structure and new roles and responsibilities for heads of business functions, CEOs of new business units, and country managers operating in over 100 countries. |
| Authors: | Carin-Isabel Knoop, Cate Reavis, Srikant M. Datar |
| Resource Type: | eBook. |
| Categories: | BUSINESS & ECONOMICS / General |
| Database: | eBook Collection (EBSCOhost) |
| Abstract: | In June 2000, Novartis reorganized its pharmaceutical business to form global business units in oncology, transplantation, ophthalmology, and mature products. The remaining primary care products continued to be managed within global functions (e.g., R&D and marketing). The new organization created a matrix structure and new roles and responsibilities for heads of business functions, CEOs of new business units, and country managers operating in over 100 countries. |
|---|
